Marcus Sucksdorff
2 of 4
- PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
- Journal of Neurology
- TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2023)
- Neurology, Neuroimmunology and Neuroinflammation
- Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients (2022)
- Multiple Sclerosis and Related Disorders
- Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis (2022)
- Neurology, Neuroimmunology and Neuroinflammation
- MS-taudin varhainen ja tehokas hoito kannattaa (2022)
- Erikoislääkäri
- Phenotyping of multiple sclerosis lesions according to innate immune cell activation using TSPO-PET (2022)
- Brain Communications
- Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study (2021)
- Multiple Sclerosis and Related Disorders
- High serum neurofilament associates with diffuse white matter damage in MS (2021)
- Neurology, Neuroimmunology and Neuroinflammation
- Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI (2021)
- Multiple Sclerosis and Related Disorders
- Whole Brain Adiabatic T-1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings (2021)
- Journal of Magnetic Resonance Imaging
UTU Research Portal